Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_assertion type Assertion NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_head.
- NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_assertion description "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_provenance.
- NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_assertion evidence source_evidence_literature NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_provenance.
- NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_assertion SIO_000772 21664615 NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_provenance.
- NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_assertion wasDerivedFrom befree-20140225 NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_provenance.
- NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_assertion wasGeneratedBy ECO_0000203 NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_provenance.